Regardless of billions of bucks of financial commitment, the pharmaceutical market is having difficulties to heal main ailments, from most cancers to dementia. The ordinary time taken to build a drug is about 12 several years and generally far extended, and expenses in excess of $1bn. 9 out of 10 […]
Pharmacy Industry
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PNB3PTTD7VLJVHP3T3P6542HEU.jpg "Pakistan defers decision on drug price rise as pharma firms struggle")
KARACHI, Pakistan, March 27 (Reuters) – Pakistan on Monday deferred a decision on a ask for by pharmaceutical companies to elevate the prices of extra than 100 medicines, prolonging a stand-off with an business struggling to stem losses from soaring inflation and a weakened currency. The request was talked over […]
As the U.S. drug crisis has accelerated, the pharmaceutical industry has jumped into action — particularly when it comes to naloxone, the drug used to reverse opioid overdoses. In recent years, companies have introduced a dizzying array of ambitious new naloxone products. They include a mechanized injector that gives robotic […]
With Megan R. Wilson and Ben Leonard Pharmacy benefit managers will come under scrutiny this week by both chambers of Congress. | Scott Olson/Getty Images PBMS FACE THE MUSIC — Pharmacy benefit managers are bracing for a hard week on the Hill. The Senate Finance Committee will hold a hearing […]
New York, NY, March 24, 2023 (GLOBE NEWSWIRE) — Polaris Market Research has published a new research report titled “E-pharmacy Market Share, Size, Trends, Industry Analysis Report by Drug Type (Prescription Drug, OTC Drug), By Product Type, By Payment Method, By Platform, By Regions; and Forecast, 2023-2032” in its research […]
Pharmaceutical giant AbbVie was able to delay competition to its blockbuster arthritis drug, Humira, into the US market for many years. But Americans can finally choose from one of several arthritis biosimilars, as generics for complex molecule drugs are known. Although biosimilars will sell at a list price lower than […]